Dr. Rebecca Bolling Rose, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 55 Ireland Road, Bayboro, NC 28515 Phone: 252-745-4560 Fax: 252-745-4862 |
Dr. Francis Gerard Serio, D.M.D. Dentist - Periodontics Medicare: Medicare Enrolled Practice Location: 313 Main St, Bayboro, NC 28515 Phone: 252-745-0781 |
Dr. Joshua Clayton Rose, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 55 Ireland Rd, Bayboro, NC 28515 Phone: 252-745-4560 Fax: 252-745-4862 |
Clarence Vernon Rose Jr., DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 55 Ireland Road, Bayboro, NC 28515 Phone: 252-745-4560 Fax: 252-745-4862 |
News Archive
More than 80% of first-year medical residents work more hours than allowed by national accreditation rules, according to two studies published on Wednesday in the Journal of the American Medical Association, the Washington Post reports (Washington Post, 9/6).
VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today the commercial launch of its new Annexin-Vivo 750 imaging agent for measuring and monitoring apoptosis and cell death in vivo.
UBM International Media, a wholly owned subsidiary of United Business Media plc (LSE: UBM) and AIM, the international association and recognized authority on bar code, RFID, and enterprise mobile computing, today announced that the FDA's Jay Crowley, senior advisor for patient safety, Center for Devices and Radiological Health, will deliver the keynote address for the Track & Trace Virtual Trade Show on opening day, December 2nd in the online presentation theater.
A new collaboration between Seattle Children's Research Institute and bluebird bio, Inc., a biotechnology company based in Cambridge, Mass. and Seattle, will allow researchers to develop potentially transformative gene therapies for severe genetic and rare pediatric diseases. The collaboration supports pediatric researchers in Seattle who will work with bluebird bio scientists and the company's gene editing technology to research potential cures for genetic pediatric diseases.
Researchers have found that by switching on a gene that promotes the spread of cancers, they can enhance the regeneration of damaged heart muscle. The study results, published in April 2020 in the journal Nature Communication, could mark the beginning of curative therapy for heart disease.
› Verified 4 days ago